Statistics for AnaptysBio (id:7932 ANAB)

Valuation metrics

Market cap

677.65M

Enterprise value

581.12M

Trailing P/E (ttm)

-3.66

Forward P/E

-3.47

PEG ratio

-3.47

Price/Sales (ttm)

11.85

Price/Book (mrq)

8.03

Enterprise Value/Revenue

10.16

Enterprise Value/EBITDA

-4.17

Overview

Shares outstanding

30.43M

Float

19.93M

Shares short

6.18M

% Held by insiders

0.02%

% Held by institutions

1.12%

Average volume (10 days)

423.13K

Average volume (90 days)

Price summary

52-Week low

13.36

52-Week high

41.31

52-Week change

37.58%

Beta

-0.24

50-Day moving average

29.78

200-Day moving average

27.77

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-289.75%

Operating margin

-75.81%

Operational effectiveness

Return on assets

-17.85%

Return on equity

-161.82%

Income statement

Revenue (ttm)

2.09

Revenue per share (ttm)

2.09

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-139,448,992.00

Net income to common (ttm)

-165,658,000.00

Diluted EPS (ttm)

-6.05

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

430.12M

Total cash per share (mrq)

14.14

Total debt (mrq)

367.06M

Total Debt/Equity (mrq)

435.07

Current ratio (mrq)

1.02K%

Book value per share (mrq)

2.77

Cash flow

Cash flow statement

-103,014,000.00

Levered free cash flow (LFCF)

-74,127,504.00